Tests a pharmacist-led medication support service in community pharmacies
Tests a pharmacist medication service in adults with high blood pressure or diabetes.
Plain-language title generated from the registry record
Registry title: Evaluation of Medication Management Service
Key facts
- Where
- Hong Kong, Hong KongSee the 8 sites
Where in Hong Kong
- Aberdeen Kai-Fong Welfare Association A-Lively Community PharmacyHong Kong, Hong KongTaking people
- Health In Action Community PharmacyHong Kong, Hong KongTaking people
- Hong Kong Sheng Kung Hui Welfare Council Community PharmacyHong Kong, Hong KongTaking people
- PHARM+ Haven of Hope Community PharmacyHong Kong, Hong KongTaking people
- PHARM+ Pok Oi Hospital Community PharmacyHong Kong, Hong KongTaking people
- PHARM+ St. James' Settlement Community PharmacyHong Kong, Hong KongTaking people
- PHARM+ The Lok Sin Tong Community PharmacyHong Kong, Hong KongTaking people
- PHARM+ YWCA Community PharmacyHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Hong Kong
- Trial code
- NCT06273761
- Record updated
- 23 February 2024
- Original description
Medication management services (MMS) is a pharmacist-led service of optimizing the medication use and health outcomes, by promoting medication safety and enhancing the ability in self-management of health and diseases of patients and their caregivers. Yet, only limited evidence on the implementation of MMS service in Hong Kong is available. The goal of this clinical trial is to evaluate the cost effectiveness and effects of implementing MMS in community pharmacies owned by 8 non-government organizations (NGOs) in Hong Kong on humanistic and clinical outcomes in patients with hypertension and/or type II diabetes mellitus. The clinical trial aims to look into the following aspects:Read full original descriptionShow less
Primary Care Community Pharmacy Project: Evaluation of Medication Management Service
Medication management services (MMS) is a pharmacist-led service of optimizing the medication use and health outcomes, by promoting medication safety and enhancing the ability in self-management of health and diseases of patients and their caregivers. Yet, only limited evidence on the implementation of MMS service in Hong Kong is available. The goal of this clinical trial is to evaluate the cost effectiveness and effects of implementing MMS in community pharmacies owned by 8 non-government organizations (NGOs) in Hong Kong on humanistic and clinical outcomes in patients with hypertension and/or type II diabetes mellitus. The clinical trial aims to look into the following aspects:
* To evaluate the perception and satisfaction of patients on MMS service * To investigate whether MMS could improve patients' adherence to their medication regimen, health-related quality of life, health outcomes and health service utilization, as well as their ability to understand and cope with their illness and drug-related problems * To identify and categorize the types of drug-related problems identified during MMS * To evaluate the cost-effectiveness of implementing MMS in community pharmacies
MMS services will be rolled out in a total of 8 NGO community pharmacies progressively (2 pharmacies per phase) in 4 successive phases. Participants will complete the questionnaires at the following time points throughout the trial, namely 1) during recruitment, 2) baseline (1 month before MMS), 3) 3 months after MMS begins, 4) 12 months after MMS begins, and 5) 24 months after MMS begins. Researchers will compare the results of questionnaires conducted at different time points to identify the potential changes in the effects of MMS. Furthermore, researchers will link up the electronic health records of the participants and identify the potential changes in the health outcomes and health service utilizations after receiving MMS.
Inclusion: aged 18 years or above; diagnosed with Type 2 diabetes mellitus and/or hypertension; having regular follow-up on Type 2 diabetes mellitus and/or hypertension at Hospital Authority; no A\&E admission/hospitalization in the past 3 months; no recent changes in medication regimen in the past 3 months; polypharmacy (taking 5 or more chronic medications); using at least 1 high-risk medication (Anticoagulants, Oral hypoglycaemics, Insulins, psychotropic medications or immunosuppressants); able to communicate in Cantonese and/or English.
Exclusion: aged below 18; unable to give informed consent; unable to communicate in Cantonese and/or English.